The Clorox Company (NYSE:CLX) Stake Cut by Bank of Montreal Can

Bank of Montreal Can lessened its holdings in The Clorox Company (NYSE:CLX) by 5.0% in the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 257,846 shares of the company’s stock after selling 13,639 shares during the quarter. Bank of Montreal Can owned approximately 0.21% of Clorox worth $35,222,000 at the end of the most recent quarter.

Other institutional investors have also recently added to or reduced their stakes in the company. CIBC Private Wealth Group LLC boosted its holdings in shares of Clorox by 0.5% in the 4th quarter. CIBC Private Wealth Group LLC now owns 13,900 shares of the company’s stock valued at $1,982,000 after buying an additional 66 shares during the period. Lindbrook Capital LLC boosted its stake in Clorox by 6.2% in the first quarter. Lindbrook Capital LLC now owns 1,182 shares of the company’s stock valued at $181,000 after acquiring an additional 69 shares during the period. Fiduciary Group LLC grew its holdings in shares of Clorox by 0.4% during the second quarter. Fiduciary Group LLC now owns 19,050 shares of the company’s stock valued at $2,600,000 after purchasing an additional 72 shares during the last quarter. GHP Investment Advisors Inc. raised its position in shares of Clorox by 2.0% during the 2nd quarter. GHP Investment Advisors Inc. now owns 3,634 shares of the company’s stock worth $496,000 after purchasing an additional 72 shares during the period. Finally, Mesirow Financial Investment Management Inc. lifted its holdings in shares of Clorox by 5.1% in the 2nd quarter. Mesirow Financial Investment Management Inc. now owns 1,702 shares of the company’s stock worth $233,000 after purchasing an additional 83 shares during the last quarter. Institutional investors own 78.53% of the company’s stock.

Insider Activity

In other Clorox news, EVP Angela C. Hilt sold 1,733 shares of the business’s stock in a transaction dated Friday, September 6th. The stock was sold at an average price of $165.52, for a total transaction of $286,846.16. Following the sale, the executive vice president now owns 13,471 shares in the company, valued at approximately $2,229,719.92. The transaction was disclosed in a filing with the SEC, which is available through this link. 0.51% of the stock is currently owned by company insiders.

Clorox Stock Performance

NYSE:CLX opened at $161.91 on Friday. The company has a 50-day moving average of $150.84 and a 200-day moving average of $143.96. The firm has a market cap of $20.11 billion, a price-to-earnings ratio of 84.26, a price-to-earnings-growth ratio of 3.31 and a beta of 0.40. The company has a current ratio of 1.03, a quick ratio of 0.63 and a debt-to-equity ratio of 5.04. The Clorox Company has a twelve month low of $114.68 and a twelve month high of $169.09.

Clorox (NYSE:CLX) last issued its earnings results on Thursday, August 1st. The company reported $1.82 earnings per share for the quarter, topping analysts’ consensus estimates of $1.54 by $0.28. The firm had revenue of $1.90 billion during the quarter, compared to analysts’ expectations of $1.97 billion. Clorox had a net margin of 3.95% and a return on equity of 281.12%. Analysts forecast that The Clorox Company will post 6.63 earnings per share for the current fiscal year.

Clorox Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Thursday, November 7th. Stockholders of record on Wednesday, October 23rd will be given a dividend of $1.22 per share. This represents a $4.88 dividend on an annualized basis and a dividend yield of 3.01%. The ex-dividend date is Wednesday, October 23rd. Clorox’s dividend payout ratio (DPR) is presently 252.85%.

Wall Street Analysts Forecast Growth

A number of research analysts recently commented on CLX shares. BNP Paribas upgraded Clorox to a “strong sell” rating in a research note on Friday, September 6th. Citigroup increased their price objective on shares of Clorox from $165.00 to $170.00 and gave the stock a “neutral” rating in a report on Friday, September 6th. TD Cowen assumed coverage on shares of Clorox in a research note on Tuesday, July 23rd. They set a “sell” rating and a $122.00 target price for the company. JPMorgan Chase & Co. decreased their target price on shares of Clorox from $150.00 to $148.00 and set a “neutral” rating for the company in a research report on Friday, August 2nd. Finally, Deutsche Bank Aktiengesellschaft boosted their price objective on Clorox from $144.00 to $151.00 and gave the stock a “hold” rating in a research report on Friday, August 2nd. Six research analysts have rated the stock with a sell rating and twelve have issued a hold rating to the company. Based on data from MarketBeat.com, Clorox presently has a consensus rating of “Hold” and an average target price of $143.33.

Clorox Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.